Thyroid antibodies

In shortThyroid antibodies are three different tests for three different tasks: TPO antibodies mark autoimmune inflammation (Hashimoto's thyroiditis), TSH-receptor antibodies mark receptor stimulation (Graves' disease), and thyroglobulin antibodies are needed above all to read thyroglobulin correctly. Drawing the whole bundle 'just in case' is unnecessary: the situation determines the choice.

TPO antibodies: the marker of autoimmune inflammation

Antibodies to thyroid peroxidase are aimed at the enzyme the gland uses to build hormones. Their presence speaks of autoimmune aggression against the gland — Hashimoto's thyroiditis. Scale matters here: the antibodies also occur in people with normal gland function, especially women, and by themselves they are not a disease but a marker of predisposition.

The clinical meaning of TPOAb is prognostic: when they are present, gland function (TSH) is monitored regularly, because the probability of a gradual decline is higher. Hypothyroidism guidelines describe autoimmune thyroiditis as the main cause of persistent primary hypothyroidism.

Thyroglobulin antibodies: the antibodies that interfere with measurement

Thyroglobulin antibodies also occur in autoimmune gland diseases, but their main role is different: they prevent the laboratory from measuring thyroglobulin accurately. Thyroglobulin is the protein semi-product of hormones used as a monitoring marker after treatment of differentiated thyroid cancer; antibodies distort its measurement, so they are drawn together.

The practical conclusion: TgAb without the thyroglobulin context is poorly informative. For Hashimoto's diagnostics TPOAb is primary, and TgAb is added when the question concerns interpreting thyroglobulin or when the picture is ambiguous.

TSH-receptor antibodies: the stimulator antibodies

Antibodies to TSH receptors are the mechanism of Graves' disease: they mimic TSH and make the gland work without stopping. Here antibodies are not just a marker but the direct cause of hormone excess. The test confirms the diagnosis in thyrotoxicosis, helps tell Graves' from other causes and is used to assess prognosis during treatment.

A special situation is pregnancy against Graves' disease: the antibodies cross the placenta and can stimulate the fetal gland, so their level in this situation is watched separately and attentively.

How not to mix up the indications

The selection logic is simple. Reduced gland function or suspected Hashimoto's — TPOAb. Thyrotoxicosis — TSH-receptor antibodies. Monitoring after thyroid cancer treatment with thyroglobulin measurement — TgAb paired with it. In every branch antibodies are read together with TSH and free T4: antibodies answer 'why', hormones answer 'how the gland works now'.

Positive antibodies with normal hormones are not a reason for treatment but for observation: the clinician sets the TSH monitoring interval. Any intervention is decided by gland function and clinical findings, not by antibody titre.

Three antibodies — three tasks

TPOAb — autoimmune inflammation of the gland (Hashimoto's), prognosis of function decline
TRAb — Graves' disease: confirmation, prognosis, special monitoring in pregnancy
TgAb — above all for correct thyroglobulin measurement

Markers covered in this article

TPO antibodies Anti-thyroglobulin antibodies TSH receptor antibodies TSH (thyrotropin)Free T4 Thyroglobulin

Several markers on your report?

See how MedProtect explains results in the app: the whole report, a check of the recognized values, and a clear breakdown.

Get your results explained See an example

Frequently asked questions

TPOAb is high but TSH is normal — treat it?

Elevated antibodies with normal function are a risk marker, not a disease. They require no treatment; periodic TSH monitoring is needed at the interval the clinician sets.

Which antibodies are drawn for suspected Hashimoto's?

The primary test is TPOAb. TgAb is added in ambiguous cases, and diagnosis confirmation matters most through the combination with TSH, free T4 and gland ultrasound.

Why is TgAb drawn together with thyroglobulin?

Thyroglobulin antibodies distort its measurement: without knowing their status the thyroglobulin result can be misread. That is why in post-treatment cancer monitoring they are measured as a pair.

TRAb is normal — can Graves' disease still exist?

In a small share of patients the test is negative, especially early on. The diagnosis is assembled from clinical findings, hormones and imaging; doubts are resolved by an endocrinologist.

Should antibodies be retested regularly?

Antibody titre by itself is a poor guide for monitoring: it does not correlate directly with well-being. Monitoring runs on TSH and free T4; antibodies are revisited for clinical reasons, not by the calendar.

Antibodies rise and fall — is that bad?

Titre fluctuations are usual and mean nothing by themselves: antibodies mark the presence of a process, not its activity. Monitoring follows gland function — TSH and free T4.

Sources

Thyroid peroxidase antibody: MedlinePlus Medical Encyclopedia — MedlinePlus, US National Library of Medicine. Accessed: August 30, 2026.
TSI test: MedlinePlus Medical Encyclopedia — MedlinePlus, US National Library of Medicine. Accessed: August 31, 2026.
Thyroglobulin Antibody Test: Lab Tests Online — Testing.com (AACC). Accessed: August 31, 2026.

Thyroid antibodies: why TPOAb, TgAb and TSH-receptor antibodies do not replace each other